These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26711640)

  • 21. Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
    Akinwande O; Miller A; Hayes D; O'Hara R; Tomalty D; Martin RC
    Anticancer Res; 2014 Dec; 34(12):7239-45. PubMed ID: 25503155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
    Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
    Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.
    Akinwande O; Dendy M; Ludwig JM; Kim HS
    Surg Oncol; 2017 Sep; 26(3):268-275. PubMed ID: 28807246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
    Ngo A; von Stempel C; Corbo B; Bandula S; Shiu KK; Raja J; Hague J; Evans J; Kibrya N
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):979-990. PubMed ID: 31044294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes.
    Voizard N; Ni T; Kiss A; Pugash R; Raphael MJ; Coburn N; David E
    Curr Oncol; 2022 Jan; 29(1):209-220. PubMed ID: 35049694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
    Ishikawa T; Imai M; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
    Anticancer Res; 2023 Aug; 43(8):3647-3651. PubMed ID: 37500124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases.
    Sljivic M; Sever M; Ocvirk J; Mesti T; Brecelj E; Popovic P
    Radiol Oncol; 2024 Jun; 58(2):214-220. PubMed ID: 38553252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer.
    Cruz JE; Saksena R; Jabbour SK; Nosher JL; Hermes-DeSantis E; Moss RA
    Ann Pharmacother; 2014 Dec; 48(12):1646-50. PubMed ID: 25202035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).
    Eichler K; Zangos S; Mack MG; Hammerstingl R; Gruber-Rouh T; Gallus C; Vogl TJ
    Int J Oncol; 2012 Oct; 41(4):1213-20. PubMed ID: 22842404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
    Pernot S; Pellerin O; Artru P; Montérymard C; Smith D; Raoul JL; De La Fouchardière C; Dahan L; Guimbaud R; Sefrioui D; Jouve JL; Lepage C; Tougeron D; Taieb J;
    Br J Cancer; 2020 Aug; 123(4):518-524. PubMed ID: 32507854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
    de Baere T; Tselikas L; Boige V; Ducreux M; Malka D; Goéré D; Benahim E; Deschamps F
    Bull Cancer; 2017 May; 104(5):402-406. PubMed ID: 27993355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.
    van Riel JM; van Groeningen CJ; de Greve J; Gruia G; Pinedo HM; Giaccone G
    Ann Oncol; 2004 Jan; 15(1):59-63. PubMed ID: 14679121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI.
    Arai Y; Ohtsu A; Sato Y; Aramaki T; Kato K; Hamada M; Muro K; Yamada Y; Inaba Y; Shimada Y; Boku N; Takeuchi Y; Morita S; Satake M
    J Vasc Interv Radiol; 2012 Oct; 23(10):1261-7. PubMed ID: 22922040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Bead Size Affect Patient Outcome in Irinotecan-Loaded Beads Chemoembolization Plus Systemic Chemotherapy Regimens for Liver-Dominant Colorectal Cancer? Results of an Observational Study.
    Boeken T; Moussa N; Pernot S; Abed A; Dean C; Taieb J; Sapoval M; Pellerin O
    Cardiovasc Intervent Radiol; 2020 Jun; 43(6):866-874. PubMed ID: 32103303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
    Fiorentini G; Aliberti C; Benea G; Montagnani F; Mambrini A; Ballardini PL; Cantore M
    Hepatogastroenterology; 2008; 55(88):2077-82. PubMed ID: 19260480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease.
    Young S; D'Souza D; Flanagan S; Golzarian J
    Cardiovasc Intervent Radiol; 2017 Apr; 40(4):496-501. PubMed ID: 28004168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
    Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
    Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer.
    Chen Y; Yan Z; Wang J; Wang X; Luo J; Liu Q
    Anticancer Res; 2010 Jul; 30(7):3045-9. PubMed ID: 20683053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.